MedPath

Tolvaptan Intervention study and Genetic mutation of AutosomalDominant Polycystic Kidney Disease

Not Applicable
Conditions
ADPKD
Registration Number
JPRN-jRCTs031180259
Lead Sponsor
Horie Shigeo
Brief Summary

Genetic diagnosis in ADPKD has not progressed and there are no registered cases

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
0
Inclusion Criteria

ADPKD patients without genetic mutation of disease gene(PKD1, PKD2)

Exclusion Criteria

ADPKD patients with genetic mutation of disease gene(PKD1,PKD2)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Increase Rate of Total Kidney Volume
Secondary Outcome Measures
NameTimeMethod
The Decrease rate of estimated Glomerular Filtration Rate
© Copyright 2025. All Rights Reserved by MedPath